Last reviewed · How we verify
Shandong Luye Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| an extract of Cimicifuga Foetida L. | an extract of Cimicifuga Foetida L. | marketed | Herbal extract / phytoestrogen | Women's Health / Endocrinology |
Therapeutic area mix
- Women's Health / Endocrinology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Federal University of Minas Gerais · 1 shared drug class
- Phytopharm Consulting Brazil · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Shandong Luye Pharmaceutical Co., Ltd.:
- Shandong Luye Pharmaceutical Co., Ltd. pipeline updates — RSS
- Shandong Luye Pharmaceutical Co., Ltd. pipeline updates — Atom
- Shandong Luye Pharmaceutical Co., Ltd. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Shandong Luye Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shandong-luye-pharmaceutical-co-ltd. Accessed 2026-05-17.